Forms Special Committee of the Board to Lead Evaluation of Viable Options for Maximizing Shareholder Value Engages Independent Financial and Legal Advisors to Support Thorough Process Remains Committed to Maintaining Focus on Cost Containment, Cash Preservation and Near-Term Initiatives to Enhance Value Farmingdale, NY — Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today […]

HO CHI MINH CITY — Gene Solutions, a leading multinational biotech company specializing in advanced genetic testing, and Element Biosciences, a company democratizing access to advanced life science solutions, have entered into a strategic collaboration. The collaboration was formalized with the signing of a Memorandum of Understanding (MoU) during Element Biosciences’ visit to Gene Solutions’ laboratory. This collaboration […]

Leader in spatial multi-omics technologies launches new generation of MERFISH chemistry and bridges basic and translational research with new pathology-grade, clinically relevant biomarkers CAMBRIDGE, Mass. ─ Vizgen, Inc., the life sciences company revolutionizing spatial genomics and proteomics research and driving innovation in spatial multi-omics, today announced the broad global commercial availability of MERFISH 2.0™, a next-generation spatial […]

Rebecca Bradford has been promoted to senior vice president of Government Programs and Dr. Manoj Menon and Rupali Lach have joined ATCC as chief operating officer and vice president of Commercial Operations, respectively MANASSAS, Va. — ATCC, the world’s premier biological materials management and standards organization, today announced several new leadership appointments. Rebecca Bradford, MBA, has […]

EditCo’s robust, HiBiT-tagged CRISPR knock-ins transform cells into powerful biosensors — perfect for drug discovery, cell-based assays, and protein quantification. Through this partnership, EditCo Bio expands its capabilities by incorporating Promega’s proprietary bioluminescent and protein-labeling technologies into its CRISPR-engineered cell lines, ensuring precise gene edits with functional validation. REDWOOD CITY, Calif. — EditCo Bio, Inc. […]

New QIAseq panels launched for use on next-generation sequencers to boost analysis of over 700 genes for comprehensive genomic profiling in research and clinical applications Advancing key partnerships: New QIAseq panels to be added to Element Bioscience’s Trinity workflow, new assay in development with Myriad Genetics planned for launch in 2025 QIAGEN Digital Insights introduces […]

Institutes under the Department of Biotechnology (DBT) sign Letters of Intent with Oxford Nanopore to establish next-generation genomic Centres of Excellence and new suite of R&D collaborations including in rare disease, newborn screening, oral cancer, and antimicrobial resistance (AMR) studies Oxford Nanopore Technologies, the global company behind a new generation of nanopore-based molecular sensing technology, […]

New xGen™ hybridization and wash offering is poised to revolutionize targeted next generation sequencing workflows   CORALVILLE, Iowa – Ahead of the American Association for Cancer Research (AACR) 2025 Annual Meeting, global genomics solutions leader Integrated DNA Technologies (IDT) unveiled its xGen Hybridization and Wash v3 Kit, a newly designed target enrichment solution. The user-friendly workflow enables […]

REHOVOT, Israel — Sequentify is offering research grants to accelerate high-impact genomic studies through its uniquely fast, easy-to-use, and scalable targeted library preparation technology. Designed to enable the widespread adoption of high-throughput genomic testing, Sequentify’s protocol is ideal for large-scale programs conducting targeted sequencing at the population or cohort level. We invite proposals from research […]

Combining GeneDx’s industry-leading rare disease data asset and Fabric Genomics’ AI-powered platform furthers the Company’s leadership and creates an unrivaled platform to deliver global access to genomic information Accelerates the NICU, enables newborn screening, and opens global market opportunities with on-site sequencing and decentralized interpretation GAITHERSBURG, Md. & OAKLAND, Calif.–GeneDx (Nasdaq: WGS), a leader in […]